Immediate Impact

1 from Science/Nature 58 standout
Sub-graph 1 of 23

Citing Papers

Acute graft-versus-host disease
2023 Standout
Myelodysplastic syndromes: 2023 update on diagnosis, risk‐stratification, and management
2023 Standout
5 intermediate papers

Works of Judith Marsh being referenced

European Multi-Centre Study on the Use of Anti-Thymocyte Globulin in the Treatment of Myelodysplastic Syndromes.
2005
Allogeneic Stem-Cell Transplantation Using a Reduced-Intensity Conditioning Regimen Has the Capacity to Produce Durable Remissions and Long-Term Disease-Free Survival in Patients With High-Risk Acute Myeloid Leukemia and Myelodysplasia
2005

Author Peers

Author Last Decade Papers Cites
Judith Marsh 248 4 132 85 6 300
Daniel A. Keesler 153 7 106 63 9 208
Franco Locatelli 234 22 226 130 4 310
J.R. Kendra 217 22 44 28 11 321
F D'Adamo 196 5 110 61 11 310
M Rovira 155 8 68 32 11 297
S. Couban 255 27 82 17 4 318
Nadira Azzi 90 9 134 80 12 245
Fernando Pinto 121 11 179 83 6 259
Sibel Koc 275 32 54 32 5 329
Michael Gratwohl 257 15 61 37 8 317

All Works

Loading papers...

Rankless by CCL
2026